Physician profile
Ken Carpenter
NPI 1073726964
$11,689.22
in general payments reported to CMS, 2019-2025
13 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $1,391 · 2021: $3,618 · 2022: $3,078 · 2023: $380 · 2024: $1,913 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,323 · Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,323.05 |
| Food and Beverage | $1,144.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $5,793.42 | 2020-2025 | |
| Stryker Corporation | $3,920.35 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Flex Revive |
| Arthrex, INC. | $1,415.20 | 2022 | |
| Smith+Nephew, INC. | $146.39 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Davol INC. | $120.13 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $111.13 | 2024-2025 | |
| Pacira Therapeutics, INC. | $40.46 | 2019-2021 | |
| Vericel Corporation | $36.68 | 2022-2024 | Maci |
| Heron Therapeutics, INC. | $29.00 | 2022 | |
| Janssen Biotech, INC. | $27.51 | 2022 | |
| Depuy Synthes Sales INC. | $17.60 | 2025 | Monovisc |
| Mallinckrodt Hospital Products INC. | $16.13 | 2022 | |
| Bioventus LLC | $15.22 | 2025 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.